Equillium Inc. (EQ)
NASDAQ: EQ
· Real-Time Price · USD
0.37
-0.02 (-5.13%)
At close: Jun 02, 2025, 3:57 PM
0.37
-1.02%
After-hours: Jun 02, 2025, 05:32 PM EDT
-5.13% (1D)
Bid | 0.36 |
Market Cap | 13.31M |
Revenue (ttm) | 30.41M |
Net Income (ttm) | -13.99M |
EPS (ttm) | -0.39 |
PE Ratio (ttm) | -0.96 |
Forward PE | -0.34 |
Analyst | Hold |
Ask | 0.45 |
Volume | 157,557 |
Avg. Volume (20D) | 101,534 |
Open | 0.37 |
Previous Close | 0.39 |
Day's Range | 0.35 - 0.39 |
52-Week Range | 0.34 - 1.51 |
Beta | 2.06 |
Analyst Forecast
According to 0 analyst ratings, the average rating for EQ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.08%
Equillium shares are trading lower after the compa...
Unlock content with
Pro Subscription
2 months ago
-16.93%
Equillium shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and lowered the price target from $3 to $1.

1 month ago · businesswire.com
Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504LA JOLLA, Calif.--(BUSINESS WIRE)---- $EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat ...